From: Risk factors associated with acute kidney injury in a cohort of hospitalized patients with COVID-19
Characteristics | Total (n = 1,584) | No AKI (n = 846) | AKI (n = 738) | p-value |
---|---|---|---|---|
Vasopressor support during hospitalization—n (%) | 545 (34.3) | 129 (15.3) | 416 (56.4) | < 0.001 |
Mechanical ventilation during hospitalization—n (%) | 620 (39.1) | 170 (20.1) | 450 (61) | < 0.001 |
ICU admission—n (%) | 690 (43.6) | 216 (25.5) | 474 (64.2) | < 0.001 |
Mean hospitalization—days (IQR) | 10 (12) | 8 (9) | 14 (15) | < 0.001 |
Renal replacement therapy modalities n (%) | 82 (11.1%) | |||
Peritoneal dialysis | 1 (1.2%) | |||
Intermittent hemodialysis | 27 (32.9%) | |||
CRRT | 54 (65.8%) | |||
Infection acquired during hospitalization—n (%) | 263 (16.6) | 74 (8.7) | 189 (25.6) | < 0.001 |
Bloodstream infection—n (%) | 49 (3.1) | 15 (1.8) | 34 (4.6) | < 0.001 |
Urinary tract infection—n (%) | 41 (2.6) | 12 (1.4) | 29 (3.9) | 0.002 |
Healthcare-associated pneumonia—n (%) | 80 (5.1) | 18 (2.1) | 62 (8.4) | < 0.001 |
Infection of the operative site—n (%) | 1 (0.06) | 0 (0) | 1 (0.14) | 0.284 |
Another infection during hospitalization—n (%) | 92 (5.8) | 29 (3.4) | 63 (8.5) | < 0.001 |
Intrahospital mortality—n (%) | 435 (27.5) | 99 (11.7) | 336 (45.5) | < 0.001 |